Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-03-06 @ 9:34 AM
Study NCT ID:
NCT03652233
Status:
WITHDRAWN
Last Update Posted:
2019-06-20
First Post:
2018-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-11
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-20
First Submit QC Date:
None
Study First Post Date:
2018-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-17
Last Update Post Date:
2019-06-20
Last Update Post Date Type:
ACTUAL